Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past Decade.

Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past Decade.
复制标题

影响炎症性肠病患者住院费用的趋势和因素:过去十年的两中心研究

DOI:
10.1155/2013/267630
复制
发表时间:
2013
影响因子:
2
通讯作者:
Shen J
Shen J
中科院分区:
医学4区
文献类型:
--
作者:
Xu J;Tang M;Shen J

文献摘要

参考文献

被引文献

相似文献

随着炎症性肠病(IBD)患者和住院病例的不断增加,整体医疗费用显着上升。共有来自两个大型医疗中心的 2458 名住院患者,涉及 1401 名 IBD 患者。确定了住院费用和影响费用变化的因素。从 2003 年到 2011 年,IBD 患者和住院频率显着增加(P < 0.001)。近十年来,每名患者的年住院费用、每次住院费用以及住院期间的每日费用均显着增加(均 P < 0.001)。然而,住院时间显着缩短(P < 0.001)。英夫利昔单抗是与较高住院费用相关的最显着因素(OR = 44380.09,P < 0.001)。住院时间(OR = 1.29,P < 0.001),无医疗保险(OR = 1.31,P = 0.017),CD(OR = 3.55,P < 0.001),炎症性肠病未分类(IBDU)(OR = 4.30,P < 0.0001),预后不良(OR = 6.78,P < 0.001),手术(OR = 3.16,P < 0.001)和内窥镜检查(OR = 2.44,P < 0.001)被发现是较高住院费用的预测因素。过去十年中,IBD 患者和住院频率有所增加。 CD患者在诊断时表现出一个特殊的年龄峰值,这与UC患者不同。 IBD患者住院费用增加可能与英夫利昔单抗、住院时间、医疗保险、IBD亚型、预后、手术和内窥镜检查有关。
With the growing number of patients with inflammatory bowel disease (IBD) and hospitalization cases, the overall medical care cost elevates significantly in consequence. A total of 2458 hospitalizations, involving 1401 patients with IBD, were included from two large medical centers. Hospitalization costs and factors impacting cost changes were determined. Patients with IBD and frequency of hospitalizations increased significantly from 2003 to 2011 (P < 0.001). The annual hospitalization cost per patient, cost per hospitalization, and daily cost during hospitalization increased significantly in the past decade (all P < 0.001). However, length of stay decreased significantly (P < 0.001). Infliximab was the most significant factor associated with higher hospitalization cost (OR = 44380.09, P < 0.001). Length of stay (OR = 1.29, P < 0.001), no medical insurance (OR = 1.31, P = 0.017), CD (OR = 3.55, P < 0.001), inflammatory bowel disease unclassified (IBDU) (OR = 4.30, P < 0.0001), poor prognosis (OR = 6.78, P < 0.001), surgery (OR = 3.16, P < 0.001), and endoscopy (OR = 2.44, P < 0.001) were found to be predictors of higher hospitalization costs. Patients with IBD and frequency of hospitalizations increased over the past decade. CD patients displayed a special one peak for age at diagnosis, which was different from UC patients. The increased hospitalization costs of IBD patients may be associated with infliximab, length of stay, medical insurance, subtypes of IBD, prognosis, surgery, and endoscopy.
DOI: 10.1053/j.gastro.2008.09.012
发表时间: 2008-12
期刊: GASTROENTEROLOGY
影响因子: 29.4
作者:
Kappelman, Michael D.;Rifas-Shiman, Sheryl L.;Porter, Carol Q.;Ollendorf, Daniel A.;Sandler, Robert S.;Galanko, Joseph A.;Finkelstein, Jonathan A.
通讯作者: Finkelstein, Jonathan A.
DOI: 10.1038/ajg.2010.410
发表时间: 2011-01-01
影响因子: 9.8
作者:
Leighton, Jonathan A.
通讯作者: Leighton, Jonathan A.
DOI: 10.1053/j.gastro.2007.05.051
发表时间: 2007-08-01
期刊: GASTROENTEROLOGY
影响因子: 29.4
作者:
Froslie, Kathrine Frey;Jahnsen, Jorgen;Vatn, Morten H.
通讯作者: Vatn, Morten H.
DOI: 10.3109/00365521.2012.668931
发表时间: 2012-10-01
影响因子: 1.9
作者:
Gao, Xiang;Yang, Rong-Ping;Hu, Pin-Jin
通讯作者: Hu, Pin-Jin
DOI: 10.1097/01.mib.0000201098.26450.ae
发表时间: 2006-03-01
影响因子: 4.9
作者:
Jiang, L;Xia, B;Xu, H
通讯作者: Xu, H